Lineage Cell Therapeutics files $40M ATM equity offering via B. Riley

Lineage Cell Therapeutics, Inc.

Prospectus supplement filed May 14, 2024 to sell up to $39,966,424 of common shares at-the-market.
Sales agent is B. Riley Securities, Inc. under agreement dated March 22, 2024.
Shares offered pursuant to effective shelf registration statement (File No. 333-277758).
Legal opinion from Sheppard Mullin on share legality included as exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.